| Literature DB >> 24071920 |
Adriana A Pedroso1, Anne L Hurley-Bacon, Andrea S Zedek, Tiffany W Kwan, Andrea P O Jordan, Gloria Avellaneda, Charles L Hofacre, Brian B Oakley, Stephen R Collett, John J Maurer, Margie D Lee.
Abstract
Food animal production systems have become more consolidated and integrated, producing large, concentrated animal populations and significant amounts of fecal waste. Increasing use of manure and litter as a more "natural" and affordable source of fertilizer may be contributing to contamination of fruits and vegetables with foodborne pathogens. In addition, human and animal manure have been identified as a significant source of antibiotic resistance genes thereby serving as a disseminator of resistance to soil and waterways. Therefore, identifying methods to remediate human and animal waste is critical in developing strategies to improve food safety and minimize the dissemination of antibiotic resistant bacteria. In this study, we sought to determine whether withdrawing antibiotic growth promoters or using alternatives to antibiotics would reduce the abundance of antibiotic resistance genes or prevalence of pathogens in poultry litter. Terminal restriction fragment length polymorphism (T-RFLP) paired with high throughput sequencing was used to evaluate the bacterial community composition of litter from broiler chickens that were treated with streptogramin growth-promoting antibiotics, probiotics, or prebiotics. The prevalence of resistance genes and pathogens was determined from sequencing results or PCR screens of litter community DNA. Streptogramin antibiotic usage did not elicit statistically significant differences in Shannon diversity indices or correlation coefficients among the flocks. However, T-RFLP revealed that there were inter-farm differences in the litter composition that was independent of antibiotic usage. The litter from all farms, regardless of antibiotic usage, contained streptogramin resistance genes (vatA, vatB, and vatE), macrolide-lincosamide-streptogramin B resistance genes (ermA and ermB), the tetracycline resistance gene tetM and class 1 integrons. There was inter-farm variability in the distribution of vatA and vatE with no statistically significant differences with regards to usage. Bacterial diversity was higher in litter when probiotics or prebiotics were administered to flocks but as the litter aged, diversity decreased. No statistically significant differences were detected in the abundance of class 1 integrons where 3%-5% of the community was estimated to harbor a copy. Abundance of pathogenic Clostridium species increased in aging litter despite the treatment while the abundance of tetracycline-resistant coliforms was unaffected by treatment. However some treatments decreased the prevalence of Salmonella. These findings suggest that withdrawing antibiotics or administering alternatives to antibiotics can change the litter bacterial community and reduce the prevalence of some pathogenic bacteria, but may not immediately impact the prevalence of antibiotic resistance.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24071920 PMCID: PMC3823317 DOI: 10.3390/ijerph10104534
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Experimental design and treatments for broiler chickens raised on 3 commercial poultry farms. Two houses on each farm received no antibiotics; two houses received flavomycin (2.2 g/T) in the starter, and grower feed and either flavomycin (2.2 g/T) or virginiamycin (22 g/T) in the finisher feed.
| House | Flock 1 | Flock 2 | Flock 3 | Flock 4 | Flock 5 |
|---|---|---|---|---|---|
| No AGP | No AGP | No AGP | No AGP | No AGP | |
| Starter- | Flavomycin | Flavomycin | Flavomycin | Flavomycin | Flavomycin |
| Grower- | Flavomycin | Flavomycin | Flavomycin | Flavomycin | Flavomycin |
| Finisher- | Flavomycin | Virginiamycin | Virginiamycin | Virginiamycin | Flavomycin |
Products and treatment protocols for broiler chickens raised in research facilities.
| Product (Manufacturer) | Composition | Dosage and administration |
|---|---|---|
| All-Lac (Alltech Inc., Lexington, KY, USA) | 5 g in 600 mL water for 2,000 birds | |
| All-Lac + BioMos (Alltech Inc., Lexington, KY, USA) | All-Lac plus a mannan oligosaccharide derived from the cell wall of | All-Lac: 5 g in 600 mL water for 2,000 birds, BioMos: 2 kg/T of starter feed for 10 days, 1 kg/T of grower feed to 21 days, 0.5 kg/T of finisher feed to 35 days |
| Aviguard (Microbial Developments Ltd, Malvern, UK) | Undefined bacteria collected and cultured from chicken cecum contents | 1 pack in 1,000 mL water for 2,000 birds |
| Primalac (Star-Labs, Clarksdale, MO, USA) | 1 kg/T of starter to 10 days, 1 kg /T of grower to 21 days, 0.5 kg/T of finisher to 35 days |
Figure 1Abundance of T-RFLP peaks contributing greater than 2% of total 16S rRNA signal of litter from 5 sequential flocks of broiler chickens reared on commercial poultry farms. Two houses (C and D) on each farm contained birds that were fed antibiotic growth promoters (AGP); houses A and B were fed no antibiotics. The results are shown as the proportion of total T-RFLP signal for each flock using a green → red gradient .
Diversity of bacterial communities determined by 16S rRNA T-RFLP signal of litter from 5 sequential flocks of broiler chickens raised on commercial poultry farms. Two houses on each farm contained birds that were fed the AGP flavomycin or flavomycin + virginiamycin; two houses contained birds that were not fed antibiotics.
| No antibiotic | AGP | |||
|---|---|---|---|---|
| Shannon Diversity Index | Richness | Shannon Diversity Index | Richness | |
| 3.94 ± 0.57 | 22.25 ± 4.6 | 4.11 ± 0.99 | 26.75 ± 13.1 | |
| 3.68 ± 0.76 | 17.5 ± 8.3 | 3.76 ± 0.94 | 19.75 ± 13.3 | |
| 3.85 ± 0.37 | 22.5 ± 6.4 | 3.66 ± 0.46 | 18.5 ± 3 | |
| 3.42 ± 0.42 | 18 ± 5.6 | 3.38 ± 0.06 | 12.25 ± 8.73 | |
| 3.27 ± 0.77 | 13.75 ± 6.2 | 3.83 ± 0.12 | 21.75 ± 6.8 | |
Abundance of genera contributing greater than 2% of total 16S rRNA T-RFLP signal of litter from five sequential flocks of broiler chickens raised on commercial poultry farms. Two houses on each farm contained birds that were fed the AGP flavomycin or flavomycin + virginiamycin; two houses were fed no antibiotics.
| Bacterial genus predicted by T-RFLP peak | No antibiotic * | AGP * | ||
|---|---|---|---|---|
| Farm 1 | Farm 2 | Farm 1 | Farm 2 | |
| 7.79% | 1.76% | 8.58% | 1.45% | |
| 10.98% | 13.70% | 10.49% | 11.62% | |
| 16.99% | 31.00% | 17.53% | 35.16% | |
| 13.48% | 6.35% | 11.91% | 8.16% | |
|
| 18.90% | 3.87% | 19.86% | 3.63% |
| 7.20% | 4.75% | 7.26% | 3.62% | |
|
| 11.65% | 27.32% | 12.11% | 24.80% |
| 9.21% | 12.37% | 10.45% | 11.49% | |
* No significant differences in composition were observed between treatments using Tukey test (P > 0.05).
Prevalence of resistance genes in litter obtained from 5 sequential flocks of broiler chickens raised on 3 commercial poultry farms. Two houses on each farm received no antibiotics; two houses received flavomycin or flavomycin + virginiamycin feed.
| TREATMENT * | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Farm | Farm | Farm | Farm | Farm | Farm | Farm | Farm | Farm | Farm | Farm | |||||||||||||||||||||||
| 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | ||
| Flavomycin | + | + | + | + | + | + | - | - | - | + | + | + | - | - | + | - | - | + | + | + | - | - | - | - | - | + | - | - | + | + | + | + | |
| + | + | + | + | + | + | - | - | - | - | + | + | - | - | + | - | - | + | - | + | - | - | - | - | - | + | - | - | + | + | + | + | ||
| NONE | + | + | + | + | + | + | - | - | - | + | + | + | - | - | + | - | - | + | + | + | - | - | - | - | + | + | - | - | + | + | + | + | |
| + | + | + | + | + | + | - | - | - | + | + | + | - | - | + | - | - | + | - | + | - | - | - | - | + | + | - | - | + | + | + | + | ||
| Flavomycin + Virginiamycin | - | + | + | + | + | + | - | - | - | + | - | + | - | - | + | - | - | + | + | + | - | - | - | - | + | + | - | - | - | + | + | + | |
| + | + | + | + | + | + | - | - | - | + | + | + | - | - | + | - | - | + | - | + | - | - | - | - | - | + | - | - | + | + | + | + | ||
| NONE | + | + | + | + | + | + | - | - | - | + | + | + | - | - | + | - | - | + | + | + | - | - | - | - | + | + | - | - | + | + | + | + | |
| + | + | + | + | + | + | - | - | - | + | + | + | - | - | + | - | - | + | - | + | - | - | - | - | - | + | - | - | + | + | + | + | ||
| Flavomycin + Virginiamycin | + | + | + | + | + | - | - | - | - | + | + | + | - | - | + | + | - | + | - | + | - | - | - | - | + | + | - | - | + | + | + | + | |
| + | + | + | + | + | + | - | - | - | + | + | + | - | - | + | - | - | + | - | - | - | - | - | - | + | + | - | - | + | + | + | + | ||
| NONE | + | + | + | + | + | - | - | - | - | + | - | + | - | - | + | - | - | + | - | - | - | - | - | - | - | + | - | - | + | + | + | + | |
| + | + | + | + | + | + | - | - | - | + | - | + | - | - | + | - | - | + | - | - | - | - | - | - | - | + | - | - | + | + | + | + | ||
| Flavomycin + Virginiamycin | + | + | + | + | + | + | - | - | - | + | + | + | - | - | + | - | - | + | - | - | - | - | - | - | - | + | - | - | + | - | + | + | |
| + | + | + | + | + | + | - | - | - | + | - | + | - | - | + | - | - | + | - | - | - | - | - | - | - | + | - | - | + | + | + | + | ||
| NONE | + | - | + | + | + | + | - | - | - | - | - | + | - | - | + | - | - | + | - | - | - | - | - | - | + | + | - | - | + | + | + | + | |
| - | - | + | + | + | + | - | - | - | + | + | + | - | - | + | - | - | + | - | + | - | - | - | - | - | + | - | - | + | + | + | + | ||
| Flavomycin | - | + | + | - | + | + | - | - | - | + | + | + | - | - | + | - | - | + | + | + | - | - | - | - | - | - | - | - | + | + | + | + | |
| - | + | + | - | + | + | - | - | - | + | + | + | - | - | + | - | - | + | - | + | - | - | - | - | + | + | - | - | + | + | + | + | ||
| NONE | - | + | + | + | + | + | - | - | - | + | + | + | - | - | + | - | - | + | - | + | - | - | - | - | + | + | - | - | + | + | + | + | |
| + | - | + | + | + | + | - | - | - | + | + | + | - | - | + | - | - | + | - | + | - | - | - | - | + | - | - | - | + | + | + | + | ||
| AGP | 90% | 90% | 0% | 90% | 33% | 33% | 33% | 0% | 43% | 30% | 97% | ||||||||||||||||||||||
| NONE | 83% | 97% | 0% | 87% | 33% | 33% | 30% | 0% | 50% | 33% | 100% | ||||||||||||||||||||||
* No significant differences were observed among treatments using Cochran-Armitage test (P > 0.05).
Abundance and prevalence of genera comprising litter bacterial community of broiler chickens raised in research housing and administered probiotics or prebiotics. Number of 16S rRNA sequences exhibiting 97% similarity to each genus is shown with the percentage of sequences in parentheses.
| Genera | Control | All-Lac | All-Lac + BioMos | Aviguard | Primalac |
|---|---|---|---|---|---|
| Total sequences | 19,806 | 39,357 | 91,219 | 48,226 | 76,363 |
| Number of genera | 85 | 135 | 154 | 119 | 211 |
|
| 5,605 (28.3) | 9,603 (24.4) | 32,171 (35.3) | 14,648 (30.4) | 19,138 (25.1) |
|
| 4,222 (21.3) | 9,483 (24.1) | 16,872 (18.5) | 7,839 (16.3) | 13,259 (17.4) |
|
| 1,955 (9.9) | 3,925 (10.0) | 9,424 (10.3) | 4,767 (9.9) | 7,775 (10.2) |
|
| 1,851 (9.3) | 3,412 (8.7) | 8,407 (9.2) | 5,802 (12.0) | 5,274 (6.9) |
|
| 1,272 (6.4) | 1,796 (4.6) | 5,610 (6.2) | 2,467 (5.1) | 4,793 (6.3) |
|
| 1,077 (5.4) | 1,796 (4.6) | 3,534 (3.9) | 2,698 (5.6) | 3,066 (4.0) |
|
| 948 (4.8) | 1,371 (3.5) | 2,666 (2.9) | 2,758 (5.7) | 2,660 (3.5) |
|
| 337 (1.7) | 1,291 (3.3) | 1,640 (1.8) | 796 (1.7) | 1,498 (2.0) |
|
| 295 (1.5) | 424 (1.1) | 0 (0.0) | 556 (1.2) | 1,091 (1.4) |
|
| 0 (0.0) | 548 (1.4) | 0 (0.0) | 623 (1.3) | 974 (1.3) |
|
| 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1,345 (1.8) |
|
| 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1,260 (1.7) |
* Firmicutes; ** Actinobacteria.
Figure 2Abundance of genera contributing greater than 1% to total number of 16S rRNA sequences of 4 sequential flocks of broiler chickens administered probiotics or prebiotics and reared in research housing. The abundances are shown as the proportion of total sequences for each flock .
16S rRNA composition of first and last litter sample from broiler chickens raised in research housing and administered probiotics or prebiotics.
| Treatment | Sample | Number of sequences | Number of genera | Shannon Diversity Index | Most abundant genus | |||
|---|---|---|---|---|---|---|---|---|
| First | 3181 | 40 | 2.43 (±0.05) | 78.2 | 21.8 | 0.00 | ||
| Last | 3068 | 43 | 2.72 (±0.05) | 61 | 38.9 | 0.00 | ||
| First | 2244 | 57 | 3.10 (±0.14) | 68.6 | 25.4 | 4.50 | ||
| Last | 2888 | 25 | 2.36 (±0.05) | 68.7 | 30.8 | 0.00 | ||
| First | 8949 | 72 | 2.59 (±0.03) | 78.1 | 21.8 | 0.05 | ||
| Last | 587 | 24 | 1.89 (±0.13) | 47.4 | 52.6 | 0.00 | ||
| First | 4480 | 42 | 2.56 (±0.03) | 88.4 | 11.5 | 0.04 | ||
| Last | 4468 | 42 | 2.40 (±0.03) | 64.1 | 35.1 | 0.72 | ||
| First | 2938 | 37 | 2.75 (±0.05) | 66.4 | 32.5 | 0.27 | ||
| Last | 2660 | 34 | 2.58 (±0.04) | 70.8 | 28 | 0.56 |
Figure 3Rarefaction curve for bacterial 16S rRNA gene OTUs at 97% of similarity for litter samples collected from 4 sequential flocks of broiler chickens administered probiotics or prebiotics and reared in research housing. Graph (A) analyzed by flock; graph (B) by treatment.
Figure 4Correspondence analysis of microbial community patterns generated by 16S rRNA analysis of litter samples collected from four sequential flocks of broiler chickens administered probiotics or prebiotics and reared in research housing. Each point represents a single sample; the five treatments are represented by color and symbol type as shown in the legend. Labels for each point indicate litter cycle (1–4), followed by week of sample collection (1–26).
Prevalence of Salmonella in litter of 4 sequential flocks of broiler chickens administered probiotics or prebiotics and reared in research housing.
| Flock | Control | All-Lac | All-Lac + BioMos | Aviguard | Primalac |
|---|---|---|---|---|---|
| + | - | - | + | - | |
| + | + | - | - | - | |
| - | + | - | + | - | |
| - | + | + | + | - |
Figure 5Log colony forming units (CFU) of coliforms (panel A) and tetracycline-resistant coliforms (panel B) cultured from litter collected from four sequential flocks of broiler chickens administered probiotics or prebiotics and reared in research housing.
Prevalence and abundance of class 1 integron (intI1) genes in litter obtained from four sequential flocks of broiler chickens administered probiotics or prebiotics and reared in research housing. The number (#) of eubacterial genomes and intI1 copies per 25 ng litter DNA was calculated after normalizing the quantitative PCR signal using a control strain and adjusting the signal to reflect genome numbers for the most abundant genera in broiler litter.
| Treatment | # | # eubacterial genomes * ± SD | Mean Ratio ± SD | |
|---|---|---|---|---|
| 6.30 × 107 ± 9.69 × 106 | 1.15 × 109 ± 1.23 × 107 | 0.0547 | ||
| Flock 2 | 2.69 × 107 ± 2.90 × 106 | 1.26 × 109 ± 3.03 × 108 | 0.0214 | |
| Flock 3 | 3.11 × 106 ± 1.77 × 105 | 5.25 × 108 ± 1.05 × 107 | 0.0059 | |
| Flock 4 | 2.97 × 107 ± 8.46 × 106 | 1.04 × 109 ± 5.30 × 107 | 0.0286 | 0.0277 ± 0.0204 |
| 3.30 × 107 ± 5.87 × 105 | 1.10 × 109 ± 2.54 × 108 | 0.0300 | ||
| Flock 2 | 1.59 × 107 ± 9.31 × 106 | 5.23 × 108 ± 2.74 × 107 | 0.0304 | |
| Flock 3 | 3.15 × 107 ± 6.79 × 106 | 1.29 × 109 ± 2.25 × 108 | 0.0244 | |
| Flock 4 | 4.41 × 107 ± 7.29 × 106 | 2.07 × 109 ± 1.06 × 109 | 0.0213 | 0.0265 ± 0.0044 |
| 2.31 × 107 ± 4.12 × 106 | 7.26 × 108 ± 3.76 × 107 | 0.0318 | ||
| Flock 2 | 3.38 × 107 ± 1.44 × 106 | 1.28 × 109 ± 1.29 × 108 | 0.0263 | |
| Flock 3 | 2.81 × 107 ± 2.09 × 106 | 1.10 × 109 ± 3.63 × 107 | 0.0254 | |
| Flock 4 | 2.37 × 107 ± 4.03 × 106 | 1.05 × 109 ± 4.58 × 107 | 0.0224 | 0.0265 ± 0.0039 |
| 3.25 × 107 ± 1.06 × 106 | 1.14 × 109 ± 2. 06 × 108 | 0.0286 | ||
| Flock 2 | 3.56 × 106 ± 2.02 × 105 | 7.80 × 107 ± 4.63 × 106 | 0.0456 | |
| Flock 3 | 5.98 × 107 ± 3.42 × 106 | 8.17 × 108 ± 2.67 × 107 | 0.0732 | |
| Flock 4 | 4.18 × 107 ± 2.91 × 106 | 1.06 × 109 ± 2.16 × 108 | 0.0393 | 0.0467 ± 0.0190 |
| 5.69 × 107 ± 2.06 × 107 | 7.06 × 108 ± 6.80 × 107 | 0.0806 | ||
| Flock 2 | 6.94 × 107 ± 2.61 × 107 | 1.33 × 109 ± 4.24 × 105 | 0.0520 | |
| Flock 3 | 2.76 × 107 ± 3.54 × 105 | 8.64 × 108 ± 6.04 × 107 | 0.0320 | |
| Flock 4 | 1.12 × 107 ± 7.07 × 103 | 4.27 × 108 ± 5.83 × 107 | 0.0263 | 0.0477 ± 0.0245 |
* No significant differences were observed among treatments using Tukey test (P > 0.05).